Waters (NYSE:WAT – Get Free Report) issued an update on its fourth quarter earnings guidance on Friday morning. The company provided earnings per share guidance of $3.90-4.10 for the period, compared to the consensus earnings per share estimate of $4.09. The company issued revenue guidance of +3.3-5.3% yr/yr to ~$846.5-862.9, compared to the consensus revenue estimate of $854.35 million. Waters also updated its FY 2024 guidance to 11.670-11.870 EPS.
Waters Stock Down 1.3 %
NYSE:WAT traded down $4.95 on Monday, reaching $382.26. 363,136 shares of the stock traded hands, compared to its average volume of 428,831. The company has a current ratio of 2.10, a quick ratio of 1.42 and a debt-to-equity ratio of 1.42. Waters has a 12 month low of $241.95 and a 12 month high of $391.00. The company has a market capitalization of $22.69 billion, a price-to-earnings ratio of 36.94, a PEG ratio of 6.35 and a beta of 0.97. The company’s fifty day simple moving average is $342.04 and its 200 day simple moving average is $325.28.
Waters (NYSE:WAT – Get Free Report) last announced its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.68 by $0.25. Waters had a net margin of 20.71% and a return on equity of 56.81%. The company had revenue of $740.30 million during the quarter, compared to analyst estimates of $712.99 million. During the same period in the previous year, the business posted $2.84 earnings per share. The firm’s quarterly revenue was up 4.0% compared to the same quarter last year. Equities analysts predict that Waters will post 11.6 EPS for the current fiscal year.
Analysts Set New Price Targets
Read Our Latest Analysis on Waters
About Waters
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Stories
- Five stocks we like better than Waters
- What Are Trending Stocks? Trending Stocks Explained
- Intel: Is Now the Time to Be Brave?Â
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Tickers Leading a Meme Stock Revival
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.